Specializing in early-stage clinical biotech investing, we are driven by a passion for groundbreaking scientific advancements that have the potential to revolutionize healthcare.
We invest in the in-human clinical trial phase with select biotech partners. Our focus enables us to provide capital at a pivotal juncture, enabling sponsors to advance their therapies through rigorous testing, validation, and optimization.
By aligning our investments at this critical stage, we maximize the potential for breakthroughs that can provide significant benefits for both patients and investors.